VIA
INCR

Vident Investment Advisory’s Intercure INCR Stock Holding History

Vident Investment Advisory’s Portfolio INCR Stock Details INCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-58,140
Closed -$375K – 1304
2021
Q4 		$375K Buy
+58,140
New +$417K 0.01% 1002

Other funds holding INCR

II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
RA
RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Vident Investment Advisory's INCR Position: Q1 2022 in Review

Vident Investment Advisory sold out of Intercure (INCR) in Q1 2022, closing a stake of 58,140 shares — an estimated $375K sold.

Vident Investment Advisory first reported a position in INCR in Q4 2021 and held it in 1 quarter. The position peaked at $375K in Q4 2021. 18 funds tracked by Wall St. Rank hold INCR as of Q1 2022.

  • Vident Investment Advisory reported no remaining Intercure position as of Q1 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 58,140 Intercure shares in Q1 2022, an estimated $375K.
  • Vident Investment Advisory first reported a position in Intercure in Q4 2021 and held it in 1 quarter.
  • Vident Investment Advisory's Intercure position peaked at $375K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Intercure as of Q1 2022.

Based on Vident Investment Advisory's 13F filing for Q1 2022, filed 16 May 2022.